Abstract
Red blood cell distribution width (RDW) shows the variation in size of erythrocytes in the circulation and it is obtained easily by automated blood cell counters. RDW is associated with systemic inflammation. Clinical or subclinical inflammation is usually present in pathogenesis of primary glomerular diseases (PGDs). Control of many of PGDs can be achieved by immune modulator agents and this supports the underlying systemic inflammatory process. Treatment response cannot be achieved in some patients. There is neither a standard dose nor a standard dose reduction protocol for immunosuppressive treatment in PGDs. In this aspect, use of predictive biomarkers for treatment response can protect patients from side effects of unnecessary immunosuppressive drugs. New biomarkers are essential in prediction of treatment response and prognosis of PGDs. So, studies have been focused to investigate potential clinical importance of RDW in prediction of prognosis and clinical outcome of PGDs. RDW is assessed as part of the complete blood count which is a quite cheap test, and therefore, it may be a useful novel marker for evaluation of treatment response in nephrotic syndrome due to PGDs.
Abbreviations
- Anti-PLA2R:
-
Phospholipase A2 receptor
- CRP:
-
C-reactive protein
- FSGS:
-
Focal segmental glomerulosclerosis
- FSP1+:
-
Fibroblast-specific protein 1-positive
- IgAN:
-
IgA nephropathy
- IgG:
-
Immunoglobulin G
- IgM:
-
Immunoglobulin M
- L FABP:
-
L fatty-acid-binding protein
- MCD:
-
Minimal change disease
- MG:
-
Membranous glomerulopathy
- MPGN:
-
Type 1 membranoproliferative glomerulonephritis
- MPV:
-
Mean platelet volume
- NAG:
-
N-acetyl-beta-glucosaminidase
- NHANES:
-
National health and nutrition examination survey
- NS:
-
Nephrotic syndrome
- PGDs:
-
Primary glomerular diseases
- RBC:
-
Red blood cell
- RDW:
-
Red blood cell distribution width
- SOCS:
-
Suppressors of cytokine signaling
- α1M:
-
α1-microglobulin
- β2M:
-
β2-microglobulin
References
Abdullahi H, Osman A, Rayis DA, et al. Red blood cell distribution width is not correlated with preeclampsia among pregnant Sudanese women. Diagn Pathol. 2014;9:29.
Afonso L, Zalawadiya SK, Veeranna V, et al. Relationship between red cell distribution width and microalbuminuria: a population-based study of multiethnic representative US adults. Nephron Clin Pract. 2011;119:277–82.
Appel GB, D’Agati VD. Primary and secondary (non-genetic) causes of focal and segmental glomerulosclerosis. In: Johnson RJ, Feehally J, Floege J, editors. Comprehensive clinical nephrology. 5th ed. Philadelphia: Elsevier Saunders; 2015. p. 218–30.
Arbel Y, Weitzman D, Raz R, et al. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost. 2014;111:300–7.
Atkins RC, Nikolic-Paterson DJ, Song Q, et al. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol. 1996;7:2271–8.
Badid C, Desmoulière A, McGregor B, et al. Interstitial alpha-smooth muscle actin: a prognostic marker in membranous nephropathy. Clin Nephrol. 1999;52:210–7.
Bazzi C, Rizza V, Raimondi S, et al. In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression. Clin J Am Soc Nephrol. 2009;4:929–35.
Bazzi C, Rizza V, Casellato D, et al. Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome. Biomed Res Int. 2013:941831. doi: 10.1155/2013/941831. Epub 2013 Sep 4.
Beck Jr LH, Fervenza FC, Beck DM, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011;22:1543–50.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89e95.
Brenchley PE, Coupes B, Short CD, et al. Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int. 1992;41:933–7.
Bright R. Tabular view of the morbid appearances in 100 cases connected with albuminous urine. Guy’s Hosp Rep. 1836;1:338–79.
Camici M. The nephrotic syndrome is an immunoinflammatory disorder. Med Hypotheses. 2007;68:900–5.
Caro J, Gutiérrez-Solís E, Rojas-Rivera J, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. Nephrol Dial Transplant 2015 Mar;30(3):467–74.
Cattran DC, Reich HN, Beanlands HJ, Genes, Gender and Glomerulonephritis Group, et al. The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant. 2008;23:2247–53.
Couser WG, Johnson RJ. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 2014;86:905–14.
Deegens JK, Wetzels JF. Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis. Clin Nephrol. 2007;68:201–8.
Deveci OS, Kabakci G, Tulumen E, et al. The relationship between microalbuminuria and the presence and extent of coronary atherosclerosis. Angiology. 2010;61(2):184–91.
Dillon SC, Taylor GM, Shah V. Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome. Pediatr Nephrol. 1998;12:643–7.
Feehally J, Floege J. IgA nephropathy and henoch-schönlein nephritis. In: Johnson RJ, Feehally J, Floege J, editors. Comphrensive clinical nephrology. 5th ed. Philadelphia: Elsevier Saunders; 2015. p. 266–77.
Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal. 2008;10:1923–40.
Harada K, Akai Y, Kurumatani N, et al. Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study. Nephron. 2002;92:824–6.
Harada K, Akai Y, Yamaguchi Y, et al. Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy. Nephrol Dial Transplant. 2008;23:3152–9.
Hofstra JM, Deegens JK, Willems HL, et al. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant. 2008;23:2546–51.
Huang YL, Hu ZD, Liu SJ, et al. Prognostic value of red blood cell distribution width for patients with heart failure: a systematic review and meta-analysis of cohort studies. PLoS One. 2014;18(9):e104861.
Irazabal MV, Eirin A, Lieske J, et al. Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study. Nephrol Dial Transplant. 2013;28:137–46.
Ishiguro C, Yaguchi Y, Funabiki K, et al. Serum IgA/C3 ratio may predict diagnosis and prognostic grading in patients with IgA nephropathy. Nephron. 2002;91:755–8.
Keskin KR, Aras Z, Silfeler DB, et al. Relationship of red cell distribution width with the presence and severity of preeclampsia. Clin Appl Thromb Hemost 2015 Mar; 21(2):128–31.
Kocyigit I, Yilmaz MI, Simşek Y, et al. The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome. Platelets. 2013;24:474–9.
Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133:628–32.
Mastroianni Kirsztajn G, Nishida SK, Silva MS, et al. Urinary retinol-binding protein as a prognostic marker in the treatment of nephrotic syndrome. Nephron. 2000;86:109–14.
Mathew R, Pai VR, Vijayakumar T. Comparison of microalbuminuria with biochemical and hematological parameters as a marker for renal involvement in patients at high risk for chronic kidney disease-Apilot study. Int J Sci Eng Res. 2014;5:97–100.
Ostalska-Nowicka D, Smiech M, Jaroniec M, et al. SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children. Folia Histochem Cytobiol. 2011;49:719–28.
Ozcan F, Turak O, Durak A, et al. Red cell distribution width and inflammation in patients with non-dipper hypertension. Blood Press. 2013;22:80–5.
Patel KV, Mohanty JG, Kanapuru B, et al. Association of the red cell distribution width with red blood cell deformability. Adv Exp Med Biol. 2013;765:211–6.
Peters HP, van den Brand JA, Wetzels JF. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. Neth J Med. 2009;67:54–61.
Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005;20:83–90.
Pillai S. Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun. 2013;45:97–103.
Piyaphanee N, Ma Q, Kremen O, et al. Discovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome. Proteomics Clin Appl. 2011;5:334–42.
Price-Jones C. The variation in sizes of red blood cells. Br Med J. 1910;2:1418.
Rezende SM, Lijfering WM, Rosendaal FR, et al. Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica. 2014;99:194–200.
Roy RR, Roy E, Rahman MH, et al. Serum immunoglobulin G, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. World J Pediatr. 2009;5:127–31.
Rumana J, Hanif M, Muinuddin G, et al. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome. Saudi J Kidney Dis Transplant. 2014;25:830–6.
Santín S, Tazón-Vega B, Silva I, FSGS Spanish Study Group, et al. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2011;6:344–54.
Schena FP, Alpers CE. Membranoproliferative glomerulonephritis and cryoglobulinemic glomerulonephritis. In: Johnson RJ, Feehally J, Floege J, editors. Comphrensive clinical nephrology. 5th ed. Philadelphia: Elsevier Saunders; 2015. p. 253–60.
Schmieder RE, Schutte R, Schumacher H, ONTARGET/TRANSCEND Investigators, et al. Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies. Diabetologia. 2014;57:2019–29.
Segarra-Medrano A, Jatem-Escalante E, Carnicer-Cáceres C, et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. Nefrologia. 2014;34:491–7.
Shimizu A, Takei T, Uchida K, et al. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy. Nephrology (Carlton). 2009;14:521–6.
Shin JR, Kim SM, Yoo JS, et al. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy. Korean J Intern Med. 2014;29:334–40.
Simel DL, DeLong ER, Feussner JR, et al. Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution width. Arch Intern Med. 1988;148:822–4.
Skjelbakken T, Lappegård J, Ellingsen TS, et al. Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study. J Am Heart Assoc. 2014;18(3):e001109.
Song CS, Park DI, Yoon MY, et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57:1033–8.
Spiropoulos A, Goussetis E, Margeli A, et al. Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis. Clin Chem Lab Med. 2010;48:199–203.
Su C, Liao LZ, Song Y, et al. The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis. J Thorac Dis. 2014;6:1429–40.
Torres DD, Rossini M, Manno C, et al. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int. 2008;73:327–33.
Troyanov S, Roasio L, Pandes M, et al. Renal pathology in idiopathic membranous nephropathy: a new perspective. Kidney Int. 2006;69:1641–8.
Turgutalp K, Kıykım A, Bardak S, et al. Is the red cell distribution width strong predictor for treatment response in primary glomerulonephritides? Ren Fail. 2014;36:1083–9.
Vajpayee N, Graham SS, Bem S. Basic examination of blood and bone marrow. In: McPherson RA, Pincus MR, editors. Henry’s clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia: Elsevier/Saunders; 2011. p. 30.
Van Es LA, de Heer E, Vleming LJ, et al. GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy. Kidney Int. 2008;73:1426–33.
Veeranna V, Zalawadiya SK, Panaich S, et al. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999–2004 NHANES. Int J Cardiol. 2013;168:5156–61.
Yamaguchi M, Ando M, Yamamoto R, et al. Patient age and the prognosis of idiopathic membranous nephropathy. PLoS One. 2014;9:e110376.
Yoshimoto K, Wada T, Furuichi K, et al. CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron Clin Pract. 2004;98:25–34.
Yu FT, Armstrong JK, Tripette J, et al. A local increase in red blood cell aggregation can trigger deep vein thrombosis: evidence based on quantitative cellular ultrasound imaging. J Thromb Haemost. 2011;9:481–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Definitions
- Antibodies
-
An immunoglobulin, a specialized immune protein, produced due to the introduction of an antigen into the body which possesses the significant capability to combine with the antigen that triggers its production. The production of antibodies is a major function of the immune system and is carried out by a type of white blood cell called a B cell (B lymphocyte).
- Biomarkers
-
A predictor that can be used to measure the presence or progress of a disease or the effects of treatment. For example, prostate-specific antigen is a biomarker for prostate cancer.
- End-stage renal disease
-
End-stage renal disease is the stage of kidney impairment which is irreversible, cannot be controlled by conservative management alone, and requires dialysis or kidney transplantation to maintain life.
- Inflammation
-
A protective tissue response of the organism to injury which serves to remove injurious insult and to mediate the healing process.
- Primary glomerular diseases
-
Primary glomerular diseases consist of a group of disorders characterized by pathologic alterations in normal glomerular structure and function, independent of systemic disease courses. This distinction is important because the clinical presentation and pathologic findings of glomerulopathy secondary to systemic diseases may mimic primary glomerular disorders, yet the correct diagnosis of the underlying systemic disease may significantly alter the treatment of the patient.
- Proteinuria
-
The presence of abnormally large amounts of protein in the urine, usually resulting from kidney diseases, but sometimes results from fever, excessive exercise, and other abnormal conditions. It is often defined as an amount in excess of 300 mg per day.
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Turgutalp, K., Bardak, S., Demir, S., Kıykım, A. (2015). Red Blood Cell Distribution Width: Useful Predictor for Treatment Response in Primary Glomerular Diseases. In: Patel, V. (eds) Biomarkers in Kidney Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7743-9_11-1
Download citation
DOI: https://doi.org/10.1007/978-94-007-7743-9_11-1
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Online ISBN: 978-94-007-7743-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences